ClinicalTrials.Veeva

Menu

Role of Plasma Rich Growth Factor in Repair Primary Cleft Palate (PRGF)

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Plasma Rich in Growth Factors
Cleft Palate

Treatments

Other: Placebo
Other: Plasma Rich in Growth Factors (PRGF)

Study type

Interventional

Funder types

Other

Identifiers

NCT06889181
Cleft palate - Omfs338

Details and patient eligibility

About

Does the plasma-rich growth factor (PRGF) with primary cleft palate repair accelerate wound healing and prevent post-operative oronasal fistula occurrence?

Full description

The primary objective is to assess and evaluate the improvement of wound healing (edema at 5th day post operatively) as a primary outcome, and secondary objective is to assess and evaluate the wound closure and the decreasing of the occurrence of the oronasal fistula as a secondary outcome among children with cleft palate, using plasma rich growth factor between nasal mucosa and palatal mucosa

Enrollment

36 estimated patients

Sex

All

Ages

6 to 18 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • systemically healthy patients (American Society of Anesthesiologists -ASA I and II); not older than 6-18 months
  • Patients with primary non-syndromic isolated cleft palate
  • Apprehensive to be in the study.

Exclusion criteria

  • Patients with recurrent palatal fistula
  • Existence of syndromic cleft palate
  • Blood diseases and platelet disorders (hematological disease)
  • Systematic disease radiotherapy or chemotherapy for malignancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

36 participants in 2 patient groups, including a placebo group

plasma rich growth factor (PRGF) (intervention or study group)
Active Comparator group
Description:
plasma rich growth factor (PRGF) intervention or study group Has Surgical procedures "von Langenbeck technique " to repair cleft palate and placing plasma rich growth factors between nasal and palatal tissue then primary closure intraoperatively, then patient will come for follow up visit after surgery, 1st day, 3rd, 5th day and come for follow up visits at 1 week, 1 month and 3 months postoperative
Treatment:
Other: Plasma Rich in Growth Factors (PRGF)
placebo (control group)
Placebo Comparator group
Description:
placebo (control group) Has Surgical procedures "von Langenbeck technique " to repair cleft palate primary closure, then patient will come for follow up visit after surgery, 1st day, 3rd, 5th day and come for follow up visits at 1 week, 1 month and 3 months postoperative
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems